{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:19:45Z","timestamp":1767993585591,"version":"3.49.0"},"reference-count":17,"publisher":"Consortium of Multiple Sclerosis Centers","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Urinary incontinence (UI) and fecal incontinence (FI) are challenging manifestations of multiple sclerosis (MS) that have historically been treated with limited success. Sacral neuromodulation (SNM) has provided successful resolution of UI and FI in the general population and in patients with neurologic conditions, including MS. We report on 6 patients with MS-related incontinence treated successfully with SNM and review the literature.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>Medical records were reviewed retrospectively to identify patients with MS seeking treatment for incontinence. Six patients were identified, and each is presented with follow-up assessment of the severity of UI or FI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>All 6 individuals with MS had severe incontinence that had been refractory to therapies that included medications and pelvic floor physical therapy. Five patients reported severe UI and 2 patients reported severe FI. Each patient was successfully treated with SNM, with large reductions of incontinence scores and improved quality of life.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>In this case series, SNM was effective as a treatment for UI and FI among patients with MS. These findings confirm other published series that have reported the success of SNM in patients with MS with incontinence. Sacral neuromodulation should be considered as a potential treatment option for patients with MS and UI and\/or FI.<\/jats:p>\n               <\/jats:sec>","DOI":"10.7224\/1537-2073.2022-027","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T13:44:51Z","timestamp":1675863891000},"page":"163-167","source":"Crossref","is-referenced-by-count":4,"title":["Sacral Neuromodulation Therapy for Urinary and Fecal Incontinence in Patients With Multiple Sclerosis: Report of 6 Cases and Literature Review"],"prefix":"10.7224","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7058-8298","authenticated-orcid":true,"given":"Erika","family":"Thys","sequence":"first","affiliation":[{"name":"From the Reno School of Medicine, University of Nevada, Reno, NV, USA (ET, KS)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent","family":"Sasse","sequence":"additional","affiliation":[{"name":"From the Reno School of Medicine, University of Nevada, Reno, NV, USA (ET, KS)"},{"name":"Nevada Surgical Associates, Reno, NV, USA (KS)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4242","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"issue":"11","key":"2023071216012647200_i1537-2073-25-4-163-b1","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1177\/1352458519894714","article-title":"Neuromodulation for functional bladder disorders in patients with multiple sclerosis","volume":"26","author":"Rahnama\u2019i","year":"2020","journal-title":"Mult Scler."},{"key":"2023071216012647200_i1537-2073-25-4-163-b2","volume-title":"Sacral Neuromodulation","author":"Feloney","year":"2021"},{"issue":"3","key":"2023071216012647200_i1537-2073-25-4-163-b3","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/nau.22544","article-title":"Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder","volume":"34","author":"Siegel","year":"2015","journal-title":"Neurourol Urodyn."},{"issue":"7","key":"2023071216012647200_i1537-2073-25-4-163-b4","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/ene.13010","article-title":"Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients\u2019 quality of life","volume":"23","author":"Zecca","year":"2016","journal-title":"Eur J Neurol."},{"key":"2023071216012647200_i1537-2073-25-4-163-b5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/DNND.S138835","article-title":"Neurogenic bowel dysfunction in patients with multiple sclerosis: prevalence, impact, and management strategies","volume":"8","author":"Preziosi","year":"2018","journal-title":"Degener Neurol Neuromuscul Dis."},{"issue":"1","key":"2023071216012647200_i1537-2073-25-4-163-b6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12894-020-00629-y","article-title":"A prospective observational cohort study of posterior tibial nerve stimulation in patients with multiple sclerosis: design and methods","volume":"20","author":"Lane","year":"2020","journal-title":"BMC Urol."},{"issue":"1","key":"2023071216012647200_i1537-2073-25-4-163-b7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1001\/archsurg.142.1.8","article-title":"Quality of life and morbidity after permanent sacral nerve stimulation for fecal incontinence","volume":"142","author":"Hetzer","year":"2007","journal-title":"Arch Surg."},{"issue":"1","key":"2023071216012647200_i1537-2073-25-4-163-b8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/JU.0000000000000458","article-title":"Treatment of urinary urgency incontinence using a rechargeable SNM system: 6-month results of the ARTISAN-SNM Study","volume":"203","author":"McCrery","year":"2020","journal-title":"J Urol."},{"key":"2023071216012647200_i1537-2073-25-4-163-b9","article-title":"Sacral nerve stimulation for the treatment of refractory urge incontinence","author":"Lefevre","year":"2000"},{"issue":"7","key":"2023071216012647200_i1537-2073-25-4-163-b10","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/nau.22468","article-title":"The Michigan Incontinence Symptom Index (M-ISI): a clinical measure for type, severity, and bother related to urinary incontinence","volume":"33","author":"Suskind","year":"2014","journal-title":"Neurourol Urodyn."},{"issue":"12","key":"2023071216012647200_i1537-2073-25-4-163-b11","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/BF02236199","article-title":"Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index","volume":"42","author":"Rockwood","year":"1999","journal-title":"Dis Colon Rectum."},{"issue":"1","key":"2023071216012647200_i1537-2073-25-4-163-b12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12894-015-0102-x","article-title":"Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series","volume":"15","author":"Engeler","year":"2015","journal-title":"BMC Urol."},{"issue":"2","key":"2023071216012647200_i1537-2073-25-4-163-b13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000513234","article-title":"Multiple sclerosis and incidence of urinary and fecal incontinence in almost 9,000 patients followed up for up to 10 years in Germany","volume":"55","author":"Jacob","year":"2021","journal-title":"Neuroepidemiology."},{"key":"2023071216012647200_i1537-2073-25-4-163-b14","doi-asserted-by":"publisher","first-page":"563294","DOI":"10.1155\/2013\/563294","article-title":"Neurostimulation for neurogenic bowel dysfunction","volume":"2013","author":"Wors\u00f8e","year":"2013","journal-title":"Gastroenterol Res Pract."},{"issue":"1","key":"2023071216012647200_i1537-2073-25-4-163-b15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00345-011-0669-0","article-title":"Sacral neuromodulation in patients with multiple sclerosis","volume":"30","author":"Minardi","year":"2012","journal-title":"World J Urol."},{"key":"2023071216012647200_i1537-2073-25-4-163-b16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.urology.2016.04.024","article-title":"Three-year follow-up results of a prospective, multicenter study in overactive bladder subjects treated with sacral neuromodulation","volume":"94","author":"Siegel","year":"2016","journal-title":"Urology."},{"issue":"8","key":"2023071216012647200_i1537-2073-25-4-163-b17","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/ner.13525","article-title":"Cortical, spinal, sacral, and peripheral neuromodulations as therapeutic approaches for the treatment of lower urinary tract symptoms in multiple sclerosis patients: a review","volume":"25","author":"Pericolini","year":"2022","journal-title":"Neuromodulation."}],"container-title":["International Journal of MS Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/ijmsc\/article-pdf\/25\/4\/163\/3236879\/i1537-2073-25-4-163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/ijmsc\/article-pdf\/25\/4\/163\/3236879\/i1537-2073-25-4-163.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T21:12:11Z","timestamp":1752786731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijmsc.org\/view\/sacral-neuromodulation-therapy-for-urinary-and-fecal-incontinence-in-patients-with-multiple-sclerosis-report-of-6-cases-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":17,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2,8]]},"published-print":{"date-parts":[[2023,7,1]]}},"URL":"https:\/\/doi.org\/10.7224\/1537-2073.2022-027","relation":{},"ISSN":["1537-2073"],"issn-type":[{"value":"1537-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,8]]}}}